project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 7.2; age at index: 64; days to birth: -23403; days to death: 418; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; year of death: 2009; age at diagnosis: 23403; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 1972; days to sample procurement: 0; initial weight: 1140.0; portion submitter id: TCGA-XF-A9T8-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0;